Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 29 citing articles:

The microcirculation: a key player in obesity-associated cardiovascular disease
Oana Sorop, T. Dylan Olver, Jens van de Wouw, et al.
Cardiovascular Research (2017) Vol. 113, Iss. 9, pp. 1035-1045
Open Access | Times Cited: 159
Obesity, estrogens and adipose tissue dysfunction – implications for pulmonary arterial hypertension
Kirsty M. Mair, Rosemary Gaw, Margaret R. MacLean
Pulmonary Circulation (2020) Vol. 10, Iss. 3, pp. 1-21
Open Access | Times Cited: 88
Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension
Nobuhiro Kikuchi, Kimio Satoh, Ryo Kurosawa, et al.
Circulation (2018) Vol. 138, Iss. 6, pp. 600-623
Open Access | Times Cited: 87
Obstructive Sleep Apnea, Obesity Hypoventilation Syndrome, and Pulmonary Hypertension
Sarah Bjork, Deepanjali Jain, Manuel Hache Marliere, et al.
Sleep Medicine Clinics (2024) Vol. 19, Iss. 2, pp. 307-325
Closed Access | Times Cited: 10
Pomegranate peel extract attenuates oxidative stress by decreasing coronary angiotensin-converting enzyme (ACE) activity in hypertensive female rats
Roger Lyrio dos Santos, Lais O. Dellacqua, Nathalie Tristão Banhos Delgado, et al.
Journal of Toxicology and Environmental Health (2016) Vol. 79, Iss. 21, pp. 998-1007
Closed Access | Times Cited: 49
Targeting IL-17 attenuates hypoxia-induced pulmonary hypertension through downregulation of β-catenin
Lei Wang, Jie Liu, Wang Wang, et al.
Thorax (2019) Vol. 74, Iss. 6, pp. 564-578
Open Access | Times Cited: 43
Pulmonary hypertension and insulin resistance: a mechanistic overview
Tamires M. Zanotto, Any Elisa de Souza Schmidt Gonçalves, Mário J.A. Saad
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 4
Obesity in Pulmonary Arterial Hypertension. The Pulmonary Hypertension Association Registry
Jeff Min, Rui Feng, David B. Badesch, et al.
Annals of the American Thoracic Society (2020) Vol. 18, Iss. 2, pp. 229-237
Open Access | Times Cited: 26
Pulmonary vascular dysfunction in metabolic syndrome
Conor Willson, Makiko Watanabe, Atsumi Tsuji‐Hosokawa, et al.
The Journal of Physiology (2018) Vol. 597, Iss. 4, pp. 1121-1141
Open Access | Times Cited: 21
Development of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
Grant Farr, Keyur B. Shah, Roshi Markley, et al.
Progress in Cardiovascular Diseases (2016) Vol. 59, Iss. 1, pp. 52-58
Closed Access | Times Cited: 18
Elevated pulmonary arterial pressure in Zucker diabetic fatty rats
Daniel Morales‐Cano, María Callejo, Bianca Barreira, et al.
PLoS ONE (2019) Vol. 14, Iss. 1, pp. e0211281-e0211281
Open Access | Times Cited: 17
Diagnostic and Prognostic Significance of Serum Levels of SeP (Selenoprotein P) in Patients With Pulmonary Hypertension
Nobuhiro Kikuchi, Kimio Satoh, Taijyu Satoh, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2019) Vol. 39, Iss. 12, pp. 2553-2562
Open Access | Times Cited: 17
BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension
Breanne E. McCarthy, Robyn L. McClelland, Dina Appleby, et al.
CHEST Journal (2022) Vol. 162, Iss. 2, pp. 436-447
Open Access | Times Cited: 9
Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension
Kimio Satoh, Nobuhiro Kikuchi, Taijyu Satoh, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 4081-4081
Open Access | Times Cited: 16
miR‑126a‑5p‑Dbp and miR‑31a‑Crot/Mrpl4 interaction pairs crucial for the development of hypertension and stroke
Qini Zhao, Huan Sun, Liquan Yin, et al.
Molecular Medicine Reports (2019)
Open Access | Times Cited: 15
Increased Transglutaminase 2 Expression and Activity in Rodent Models of Obesity/Metabolic Syndrome and Aging
Krishna C. Penumatsa, Inês Falcão‐Pires, Sara Leite, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 13
Obesity, Metabolic Syndrome, and Pulmonary Hypertension
Jessica Badlam
Respiratory medicine (2024), pp. 267-287
Closed Access | Times Cited: 1
Pulmonary Circulation in Obesity, Diabetes, and Metabolic Syndrome
Phue Khaing, Pooja Pandit, Bharat Awsare, et al.
Comprehensive physiology (2019), pp. 297-316
Closed Access | Times Cited: 11
The substitution of SERCA2 redox cysteine 674 promotes pulmonary vascular remodeling by activating IRE1α/XBP1s pathway
Weimin Yu, Gang Xu, Hui Chen, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 5, pp. 2315-2329
Open Access | Times Cited: 6
Pulmonary arterial remodelling by deficiency of peroxisome proliferator-activated receptor-γ in murine vascular smooth muscle cells occurs independently of obesity-related pulmonary hypertension
Evren Caglayan, Manuela Trappiel, Arnica Behringer, et al.
Respiratory Research (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Influence of gender in monocrotaline and chronic hypoxia induced pulmonary hypertension in obese rats and mice
Balram Neupane, Akylbek Sydykov, Kabita Pradhan, et al.
Respiratory Research (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 8
Comparison of echocardiographic parameters between pre-clinical and clinical advanced diastolic dysfunction patients
Shemy Carasso, Lynne Williams, Yevgeni Hazanov, et al.
International Journal of Cardiology (2016) Vol. 224, pp. 165-169
Closed Access | Times Cited: 7
A review of rodent models for metabolic syndromes and pulmonary hypertension
Magdalena Jasińska-Stroschein
Toxicology and Applied Pharmacology (2021) Vol. 425, pp. 115599-115599
Open Access | Times Cited: 4
Obesity and pulmonary hypertension
MaryEllen Antkowiak, Richard N. Channick
Elsevier eBooks (2018), pp. 201-226
Closed Access | Times Cited: 3
mTOR in the Development of Hypoxic Pulmonary Hypertension Associated with Cardiometabolic Risk Factors
Karen Flores, Carla Almeida, Karem Arriaza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11023-11023
Open Access
Page 1 - Next Page

Scroll to top